FDA D.I.S.C.O. Burst Edition: FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid tumors who require systemic treatment
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) ›03:30 | Jan 8th, 2024
Listen to a soundcast of the November 27, 2023 FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid tumors who require systemic treatment.
Recommendations